Theranostics Health
Avant Completes Acquisitions of Amarantus, Theranostics Health
The deals bring together Avant's ovarian cancer diagnostic, Amarantus' multiple sclerosis and Alzheimer's disease assays, and Theranostics' CLIA lab.
The deal brings together three firms that have struggled to ramp their test businesses in hopes that the combined outfit will be better positioned to succeed.
Avant, Amarantus Diagnostics Add Theranostics Health to Planned Merger
Avant and Amarantus, which agreed to merge in January, have now signed a deal to acquire Theranostics Health and its CLIA-certified laboratory.
After Expanding Breast Cancer Assay, Theranostics to Launch Colorectal, Pancreatic Cancer Tests
Premium
The assays, which the company plans to launch at the end of the month, will use RPPA measurements of cancer signaling pathways to guide patient treatment.
Theranostics Expands Collaborations with Avera Health
Avera Health will offer the TheraLink Assay to its employees and conduct studies to establish the clinical utility of the proteomic panel.
Oct 31, 2014
Oct 29, 2014
Aug 31, 2012
Nov 12, 2010
Aug 14, 2010
Jan 28, 2009